Rheumatology Flashcards
Polymyositis features
proximal muscle weakness +/- tenderness
Raynauds
respiratory muscle weakness
interstitial lung disease
dysphagia, dysphonia
CK
elevated muscle enzymes
anti-synthetase antibodies; anti-Jo-1 antibodies
features of antiphospholipid syndrome
venous/arterial thrombosis
recurrent miscarriages
livedo reticularis
associated with SLE
rise in APTT
thrombocytopenia
antiphospholipid antibodies
anticardiolipin antibodies
anti-beta2 glycoprotein
lupus anticoagulant
management of antiphospholipid syndrome
primary thromboprophylaxis with low-dose aspirin
lifelong warfarin
rheumatoid arthritis antibodies
RF
Anti-CCP before RF positive
dermatomyositis antibodies
ANA positive in majority
antibodies against histidine-tRNA ligase (Jo-1)
SRP antibodies
anti-Mi-2 antibodies
limited cutaneous systemic sclerosis antibodies
anti-centromere antibodies
diffuse cutaneous systemic sclerosis antibodies
anti scl-70 antibodies
predisposing factors to gout
diuretics; thiazides, furosemide
drugs: ciclosporin, alcohol, cytotoxic agents, pyrazinamide, aspirin
CKD
lead toxicity
myeloproliferative/lymphoproliferative disorder
cytotoxic drugs
severe psorasis
Lesch-Nyhan syndrome
radiological features of gout
joint effusion
punched-out erosions with sclerotic margins
eccenteric erosions
soft tissue tophi
urate-lowering (allopurinol or febuxostat) therapy in gout
2 weeks after acute attack
>2 attacks in 12 months
tophi
renal disease
uric acid renal stones
prophylaxis if on cytotoxics or diuretics
risk factors for pseudogout
haemochromatosis
hyperparathyroidism
low magnesium and low phosphate
acromegaly, Wilsons disease
lupus antibodies
ANA positive
RF
anti-DsDNA
anti-smith
management of SLE
NSAIDs sun lotion
hydroxychloroquine
neonatal lupus antibodies
anti-Ro (SSA) antibodies
Limited cutaneous systemic sclerosis features
Raynaud’s
scleroderma; face and distal limbs
a subtype of limited systemic sclerosis is CREST syndrome: Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, Telangiectasia
systemic sclerosis antibodies
ANA
RF
anti-scl-70 associated with diffuse cutaneous systemic sclerosis
anti-centromere associated with limited cutaneous systemic sclerosis
Diffuse cutaneous systemic sclerosis features
scleroderma; trunk and proximal limbs
interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH)